Every few years one of these two styles is declared dead. Value was dead through most of the 2010s. Growth was dead in 2022. Both obituaries were written by people extrapolating the last three years, which is the only skill the market punishes reliably.
What the two words actually mean
Value buys businesses trading cheap relative to something measurable — earnings, book value, cash flow, replacement cost — on the reasoning that the market has over-punished them and the price will revert. The bet is on mispricing.
Growth buys businesses whose earnings are expected to compound faster than average, and accepts paying a high multiple to own them. The bet is on durable compounding outrunning the price you paid.
Neither is “safer”. They fail in different ways, and that is the useful part:
- Value's failure mode is the value trap — the stock was cheap because the business is deteriorating, and it stays cheap all the way down. Cheapness is not a catalyst.
- Growth's failure mode is multiple compression — the company grows exactly as forecast, and the stock still falls because the market decided 60× earnings was too much to pay. You were right about the business and lost money anyway.
Check a fund's P/E and P/B on the fund page: they tell you which side of this line the portfolio actually sits on, regardless of what the scheme is called.
Where SEBI draws the line
In India this is not purely stylistic — it is a category with a rule.
A Value Fund must follow a value investment strategy, and under SEBI's revised categorisation must hold at least 80% of assets in equity (raised from the earlier 65%). A Contra Fund — the contrarian cousin — carries the same floor.
The older rule allowed an AMC to offer either a Value fund or a Contra fund, not both. The revised framework permits both, on the condition that the portfolio overlap between the two does not exceed 50% — a rule aimed squarely at the practice of launching two schemes that were the same portfolio wearing different labels.
There is no “Growth Fund” category. Growth investing in India lives inside Flexi Cap, Large Cap, Large & Mid Cap and Focused mandates, which is why you cannot screen for it by category and have to read the portfolio instead.
⚠️ Category rules and the 80% floors here reflect SEBI's 2026 categorisation review, which existing schemes are being transitioned into. Check the current scheme information document before relying on any specific number.
Which one wins
Over very long horizons the honest answer is neither reliably, and the leadership alternates in multi-year blocks.
What the evidence does support is that the cycles are long enough to break your conviction. Value underperformed growth for the better part of a decade globally before turning sharply. In India, value-oriented schemes spent 2014–2020 looking obsolete and then had a run that made the previous six years look like a set-up. An investor who switched at the point of maximum frustration — which is when switching feels most justified — captured both the underperformance and none of the recovery.
That is the real finding. Not which style wins, but that style timing is the thing that loses.
There is also a structural point worth knowing: much of what is sold as growth in a rising Indian market is really momentum, and momentum's crashes are sharper and less forgiving than either style's. A fund whose top holdings are whatever ran hardest last year is not a growth fund; it is a trend-follower with a nicer prospectus.
How to actually use this
- Own both, and stop choosing. A diversified flexi-cap or index core holds value and growth simultaneously and rebalances between them without a tax event or a decision. For most people this ends the question.
- If you tilt, tilt small and tilt permanently. A 10–20% style sleeve held through the cycle is a strategy. The same sleeve entered after three good years is a return chase.
- Judge a style fund against style peers. A value fund measured against a broad index during a growth run will look incompetent when it was merely doing its job. Use the peer group and read rolling returns, which show consistency rather than one lucky window.
- Watch for style drift. A value manager quietly buying expensive compounders after three bad years has abandoned the mandate you bought — and usually at exactly the wrong moment. Rising P/E on a value fund's factsheet is the tell, and it is one of the few genuine reasons to sell.
Pitfalls to avoid
- Switching styles at the point of maximum pain. This is the single most expensive move in the whole debate, and it feels like discipline.
- Confusing cheap with value. A low P/E on a business losing market share is a warning, not a discount.
- Confusing quality with growth. Steady compounders bought at fair prices are a third thing again, and they behave differently from both.
- Holding a value fund and a contra fund from the same house. Even with the 50% overlap cap, you are running one bet at double weight.
- Judging over three years. These cycles are longer than that. A three-year verdict on a style is a verdict on a market regime.
Key takeaway
Value and growth are two different bets — on mispricing and on durable compounding — with two different failure modes, and their leadership alternates in cycles long enough to exhaust anybody's patience. The reliable loser is not either style, it is the investor who rotates between them at the moment the switch feels most obvious. Own both through a diversified core, tilt small and permanently if you must tilt, and judge a style fund against its own peer group rather than against whatever is currently winning.
Terms used here
See the funds
More in Module 6 — Inside the specific fund sub-categories
Micro-cap funds: the riskiest edge of Indian equity
SEBI has no micro-cap category — you are buying the undefined tail below the small-cap floor, where the premium is for illiquidity and fragility rather than volatility.
Dividend yield funds: do high-dividend stocks make better funds?
A value strategy wearing an income costume. Why the dividends land in the NAV rather than your bank account, and why an SWP beats this for cash flow.
Focused funds: is holding only 30 stocks conviction or recklessness?
The stock cap is a multiplier on the manager's process, not a strategy — it widens the distribution of outcomes without raising the expected return.
Contra funds: betting against the crowd, and what being early costs
Overreaction is a real and repeatable market failure. The price of exploiting it is years of looking wrong in public, which is why so few investors collect.
ESG funds: investing with a conscience, or paying for a label?
India's rules are stricter than most — six declared strategies and a 65% assured-BRSR-Core requirement. What that does and does not settle about greenwashing.
Infrastructure and PSU funds: riding the government capex cycle
A leveraged bet on capex and policy, with a specific trap: cyclicals look cheapest exactly when earnings have peaked, which is also when the schemes get launched.
Consumption and FMCG funds: the defensive play that isn't always defensive
The steadiest earnings in the market, already priced as such — plus a rural and input-cost macro exposure most buyers of a 'defensive' fund never notice.
Banking and financial services funds: doubling a bet you already hold
Financials are already the largest sector in every diversified portfolio. Lending books their revenue years before they discover its cost — which is what makes the cycle so dangerous.
Dynamic bond funds: letting a manager call the interest-rate cycle
You are not buying a duration, you are buying a forecast — of the one variable the bond market has already priced. Why choosing the duration yourself usually wins.